A new isoquinolinium derivative, Cadein1, preferentially induces apoptosis in p53-defective cancer cells with functional mismatch repair via a p38-dependent pathway.

The Journal of Biological Chemistry
Eun Ryoung JangKiwon Song

Abstract

We screened a protoberberine backbone derivative library for compounds with anti-proliferative effects on p53-defective cancer cells. A compound identified from this small molecule library, cadein1 (cancer-selective death inducer 1), an isoquinolinium derivative, effectively leads to a G(2)/M delay and caspase-dependent apoptosis in various carcinoma cells with non- functional p53. The ability of cadein1 to induce apoptosis in p53-defective colon cancer cells was tightly linked to the presence of a functional DNA mismatch repair (MMR) system, which is an important determinant in chemosensitivity. Cadein1 was very effective in MMR(+)/p53(-) cells, whereas it was not effective in p53(+) cells regardless of the MMR status. Consistently, when the function of MMR was blocked with short hairpin RNA in SW620 (MMR(+)/p53(-)) cells, cadein1 was no longer effective in inducing apoptosis. Besides, the inhibition of p53 increased the pro-apoptotic effect of cadein1 in HEK293 (MMR(+)/p53(+)) cells, whereas it did not affect the response to cadein1 in RKO (MMR(-)/p53(+)) cells. The apoptotic effects of cadein1 depended on the activation of p38 but not on the activation of Chk2 or other stress-activated kinases in p53-defective cells. Taken t...Continue Reading

References

Jun 1, 1995·Current Opinion in Genetics & Development·R Fishel, R D Kolodner
Mar 18, 1994·Science·N PapadopoulosM D Adams
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A KatP Modrich
Oct 23, 1997·Journal of the American Dietetic Association·W J Craig
Sep 9, 1999·The American Journal of Clinical Nutrition·W J Craig
Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·M J Hickman, L D Samson
Aug 15, 2000·Journal of Ethnopharmacology·L OrfilaF Arvelo
Nov 26, 2002·Nature Genetics·Kevin D BrownR Baskaran
Oct 2, 2003·International Journal of Cancer. Journal International Du Cancer·Norio IizukaKiwamu Okita
Oct 25, 2003·Oncogene·Wafik S El-Deiry
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yi Wang, Jun Qin
Apr 28, 2004·Biochemical and Biophysical Research Communications·Kazuhiko YamaneTimothy J Kinsella
May 4, 2005·Biochemical and Biophysical Research Communications·Marco CorazzariMauro Piacentini
Nov 8, 2006·Carcinogenesis·Aime A Levesque, Alan Eastman
Mar 27, 2007·Trends in Molecular Medicine·José J FusterVicente Andrés

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.